VLCAD Deficiency Risk Stratification and Monitoring

Stratifies risk in very-long-chain acyl-CoA dehydrogenase (VLCAD) deficiency using C14:1 carnitine levels, cardiac involvement, exercise-induced rhabdomyolysis history, and MCT supplementation adequacy.

Weight
Height
Clinical Guidance

BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).

BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.
Advertisement

How It Works

Stratifies risk in very-long-chain acyl-CoA dehydrogenase (VLCAD) deficiency using C14:1 carnitine levels, cardiac involvement, exercise-induced rhabdomyolysis history, and MCT supplementation adequacy

Each component has a specific meaning:

  • C14:1 carnitine levels — The c14:1 carnitine levels recorded for the scenario being assessed.
  • Cardiac involvement — The cardiac involvement recorded for the scenario being assessed.
  • Exercise-induced rhabdomyolysis history — The exercise-induced rhabdomyolysis history recorded for the scenario being assessed.
  • MCT supplementation adequacy — The mct supplementation adequacy recorded for the scenario being assessed.

Note: Interpret the vlcad risk score result against the thresholds and context described above.

How to Use

Enter the C14:1 carnitine levels, cardiac involvement, exercise-induced rhabdomyolysis history, MCT supplementation adequacy for the scenario you are assessing. Stratifies risk in very-long-chain acyl-CoA dehydrogenase (VLCAD) deficiency using C14:1 carnitine levels, cardiac involvement, exercise-induced rhabdomyolysis history, and MCT supplementation adequacy. Use the vlcad risk score result to inform your calculation.

Frequently Asked Questions